Activation of multiple proto-oncogenic tyrosine kinases in breast cancer via loss of the PTPN12 phosphatase.
Sun, Tingting; Aceto, Nicola; Meerbrey, Kristen L; Kessler, Jessica D; Zhou, Chunshui; Migliaccio, Ilenia; Nguyen, Don X; Pavlova, Natalya N; Botero, Maria; Huang, Jian; Bernardi, Ronald J; Schmitt, Earlene; Hu, Guang; Li, Mamie Z; Dephoure, Noah; Gygi, Steven P; Rao, Mitchell; Creighton, Chad J; Hilsenbeck, Susan G; Shaw, Chad A; Muzny, Donna; Gibbs, Richard A; Wheeler, David A; Osborne, C Kent; Schiff, Rachel; Bentires-Alj, Mohamed; Elledge, Stephen J; Westbrook, Thomas F.
; 144(5): 703-18, 2011 Mar 04.
Artigo em Inglês | MEDLINE | ID: mdl-21376233
Structure and Molecular Dynamics Simulations of Protein Tyrosine Phosphatase Non-Receptor 12 Provide Insights into the Catalytic Mechanism of the Enzyme.
Switching of the substrate specificity of protein tyrosine phosphatase N12 by cyclin-dependent kinase 2 phosphorylation orchestrating 2 oncogenic pathways.
Progress in the correlation between PTPN12 gene expression and human tumors.
The phosphatase PTP-PEST promotes secondary T cell responses by dephosphorylating the protein tyrosine kinase Pyk2.
Identification of Novel Candidate Genes for Early-Onset Colorectal Cancer Susceptibility.
Expression, purification and characterization of a catalytic domain of human protein tyrosine phosphatase non-receptor 12 (PTPN12) in Escherichia coli with FKBP-type PPIase as a chaperon.
Identifying the role of PTPN12 expression in predicting the efficacy of capecitabine to neoadjuvant chemotherapy in breast cancer treatment.
Prolactin-induced PAK1 tyrosyl phosphorylation promotes FAK dephosphorylation, breast cancer cell motility, invasion and metastasis.
Clinical implications of a novel prognostic factor AIFM3 in breast cancer patients.
PTP-PEST targets a novel tyrosine site in p120 catenin to control epithelial cell motility and Rho GTPase activity.